Access Pharmaceuticals Inc., of Dallas, named Esteban Cvitkovic senior director of oncology clinical research and development.
Affymax Inc., of Palo Alto, Calif., promoted Anne-Marie Duliege to chief medical officer and Christine Conroy to vice president of regulatory affairs and good clinical practice compliance.
Alpha Innotech Corp., of San Leandro, Calif., named Joseph D. Keegan and Gus E. Davis to its board of directors.
Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Laura Brege to its board of directors.
Ardea Biosciences Inc., of Carlsbad, Calif., named Patrick M. O'Connor senior vice president of research and preclinical development and chief scientific officer.
BioCryst Pharmaceuticals Inc., of Birmingham, Ala., appointed Stuart Grant senior vice president and chief financial officer.
Elusys Therapeutics Inc., of Pine Brook, N.J., named Ron Eastman chairman of its board of directors and promoted James P. Porter to vice president of development and manufacturing.
Gene Logic Inc., of Gaithersburg, Md., appointed Stephen R. Donahue senior vice president of clinical development.
InNexus Biotechnology Inc., of Vancouver, British Columbia, named Jur Strobos chief medical officer.
Intellect Neurosciences Inc., of New York, appointed Thomas M. Wisniewski to its clinical advisory board.